Abstract
ObjectiveTo evaluate the predictive effect of molecular and clinical characteristics for the efficacy of anti-programmed cell death 1 (PD-1)/programmed cell death ligand-1 (PD-L1) immunotherapy in patients with non-small cell lung...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have